Mobile Health Intervention to Increase Activity in Heart Failure Study
MObile Health Intervention to INcrease Activity in Heart Failure Study: A Micro-Randomized Trial
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether mobile health tools help adults with heart failure become more active and stay active. The tools include activity reminders, a digital health coach, and an app to set goals and track activity. It is for Michigan Medicine patients with heart failure.
Physical activity is known to help patients with heart failure feel better and live longer though few patients with heart failure are sufficiently active. This study is evaluating whether a mobile health intervention can help patients with heart failure increase physical activity levels and remain active over time. The mobile health intervention consists of three parts: Notifications encouraging physical activity, a digital health coach trained in motivational interviewing, and a mobile application which encourages goal setting and activity monitoring.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are a Michigan Medicine patient diagnosed with heart failure.
- You are age 18 or older at screening and can agree to join the study.
- You have NYHA class 2 or 3 heart failure symptoms, which limit physical activity.
- Your treating clinician says it is safe for you to be active at home.
- You own an Apple or Android smartphone that works with the study tools.
- You speak and read English fluently.
Who can't join
- You were in the hospital for heart failure in the past 6 weeks.
- You have a bone, joint, muscle, brain, or nerve condition that greatly limits activity.
- You have more than mild problems with memory or thinking.
- You are receiving hospice care.
- You have severely narrowed heart valves, a fast rhythm in the heart’s lower chambers during exercise, or blocked blood flow in the left main heart artery or the first part of the left anterior descending heart artery.
- You have high blood pressure in the lungs treated with medicine you breathe in or receive through a vein.
- You are pregnant or plan to become pregnant.
- The study team decides it is not safe for you to take part.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Michigan Medicine patient with a diagnosis of heart failure (HF) * Age 18 years and older at screening and able to provide consent * New York Heart Association class 2 or 3 HF symptoms * Safe for home physical activity as determined by treating clinician * Own a smartphone with a compatible Apple or Android operating system * Fluent in spoken and written English Exclusion Criteria: * Hospitalized for HF within the prior 6 weeks * Orthopedic or neurological condition significantly limiting physical activity * Greater than mild cognitive impairment * Enrolled in hospice care * Severe valvular stenosis * Exercise-induced ventricular tachycardia * Obstructive left main or proximal left anterior descending coronary artery disease * Pulmonary hypertension treated with inhaled or intravenous therapy * Currently pregnant or planning to become pregnant * Determined to be unsafe for participation as assessed by the investigative team.
Study sites (1)
MI
- University of Michigan · Ann Arbor, MI 48109Chelsie Gesierich, MPH · Study contact · 734-998-0514 · MOVIN-HF-Study@med.umich.eduJessica Golbus, MD, MS · Principal investigatorMore trials in Ann Arbor